Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis

Project Details

StatusActive
Effective start/end date24/05/2129/12/23

Funding

  • Avalyn Pharma: AUD20,000.00
  • Avalyn Pharma: AUD10,000.00
  • Avalyn Pharma: AUD30,000.00